Dr. Scott M. Glaser
Claim this profileCity of Hope Comprehensive Cancer Center
Studies Skin Cancer
Studies Breast Cancer
4 reported clinical trials
14 drugs studied
Area of expertise
1Skin Cancer
Stage IV
2Breast Cancer
Stage IV
HER2 negative
ER negative
Affiliated Hospitals
Clinical Trials Scott M. Glaser is currently running
Stereotactic Radiation + Immunotherapy
for Kidney Cancer
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has spread to other places in the body (metastatic). Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses of radiation over a shorter period and cause less damage to normal tissue. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, avelumab, and pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving SABR in combination with standard of care immunotherapy may help shrink or stabilize the cancer in patients with renal cell cancer.
Recruiting1 award Phase 221 criteria
Topical Agents
for Radiation Dermatitis in Breast Cancer
This clinical trial compares two supplemental topical agents (Aquaphor and Miaderm) for the treatment of acute radiation dermatitis in patients with breast cancer undergoing radiation therapy. Radiation dermatitis is a radiation-induced skin reaction which can cause itching, swelling, pain, and general discomfort. Aquaphor is a commonly available, inexpensive, petrolatum-based multi-purpose ointment designed to protect and sooth extremely dry skin, chapped lips, cracked hands and feet, minor cuts and burns, and many other skin irritations. Miaderm is a water-based cream and contains ingredients like calendula, hyaluronate, and aloe vera which may help reduce occurrence and severity of radiation dermatitis. Both are commonly recommended and used by breast cancer patients undergoing external beam radiation therapy (EBRT). However, it is not known whether one is better than the other in treating or preventing radiation dermatitis.
Recruiting1 award Phase 13 criteria
More about Scott M. Glaser
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Scott M. Glaser has experience with
- Aquaphor
- Miaderm
- Paclitaxel
- Radium-223 Dichloride
- Apalutamide
- Targeted Radiation Therapy
Breakdown of trials Scott M. Glaser has run
Skin Cancer
Breast Cancer
Ductal Carcinoma
Perianal Dermatitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott M. Glaser specialize in?
Scott M. Glaser focuses on Skin Cancer and Breast Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Scott M. Glaser currently recruiting for clinical trials?
Yes, Scott M. Glaser is currently recruiting for 3 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Scott M. Glaser has studied deeply?
Yes, Scott M. Glaser has studied treatments such as Aquaphor, Miaderm, Paclitaxel.
What is the best way to schedule an appointment with Scott M. Glaser?
Apply for one of the trials that Scott M. Glaser is conducting.
What is the office address of Scott M. Glaser?
The office of Scott M. Glaser is located at: City of Hope Comprehensive Cancer Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.